|
1
|
van den Bosch MA and Defreyne L:
Hepatocellular carcinoma. Lancet. 380:469–470; author reply
470–461. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Steeg PS: Tumor metastasis: Mechanistic
insights and clinical challenges. Nat Med. 12:895–904. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mosser DM and Edwards JP: Exploring the
full spectrum of macrophage activation. Nat Rev Immunol. 8:958–969.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pollard JW: Tumour-educated macrophages
promote tumour progression and metastasis. Nat Rev Cancer. 4:71–78.
2004. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fridman WH, Pagès F, Sautès-Fridman C and
Galon J: The immune contexture in human tumours: Impact on clinical
outcome. Nat Rev Cancer. 12:298–306. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Balkwill F and Mantovani A: Inflammation
and cancer: Back to Virchow? Lancet. 357:539–545. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Noy R and Pollard JW: Tumor-associated
macrophages: From mechanisms to therapy. Immunity. 41:49–61. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Qian BZ and Pollard JW: Macrophage
diversity enhances tumor progression and metastasis. Cell.
141:39–51. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sica A, Larghi P, Mancino A, Rubino L,
Porta C, Totaro MG, Rimoldi M, Biswas SK, Allavena P and Mantovani
A: Macrophage polarization in tumour progression. Semin Cancer
Biol. 18:349–355. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Atanasov G, Hau HM, Dietel C, Benzing C,
Krenzien F, Brandl A, Wiltberger G, Matia I, Prager I, Schierle K,
et al: Prognostic significance of macrophage invasion in hilar
cholangiocarcinoma. BMC Cancer. 15:7902015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lawrence T and Natoli G: Transcriptional
regulation of macrophage polarization: Enabling diversity with
identity. Nat Rev Immunol. 11:750–761. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mantovani A, Allavena P, Sica A and
Balkwill F: Cancer-related inflammation. Nature. 454:436–444. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Welsh TJ, Green RH, Richardson D, Waller
DA, OByrne KJ and Bradding P: Macrophage and mast-cell invasion of
tumor cell islets confers a marked survival advantage in
non-small-cell lung cancer. J Clin Oncol. 23:8959–8967. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hutterer GC, Pichler M, Chromecki TF,
Strini KA, Klatte T, Pummer K, Remzi M, Mannweiler S and Zigeuner
R: Tumour-associated macrophages might represent a favourable
prognostic indicator in patients with papillary renal cell
carcinoma. Histopathology. 63:309–315. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Falini B, Flenghi L, Pileri S, Gambacorta
M, Bigerna B, Durkop H, Eitelbach F, Thiele J, Pacini R, Cavaliere
A, et al: PG-M1: A new monoclonal antibody directed against a
fixative-resistant epitope on the macrophage-restricted form of the
CD68 molecule. Am J Pathol. 142:1359–1372. 1993.PubMed/NCBI
|
|
16
|
Huang H, Chen A, Wang T, Wang M, Ning X,
He M, Hu Y, Yuan L, Li S, Wang Q, et al: Detecting cell-in-cell
structures in human tumor samples by E-cadherin/CD68/CD45 triple
staining. Oncotarget. 6:20278–20287. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gordon S: Alternative activation of
macrophages. Nat Rev Immunol. 3:23–35. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gazi U and Martinez-Pomares L: Influence
of the mannose receptor in host immune responses. Immunobiology.
214:554–561. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Medrek C, Pontén F, Jirström K and
Leandersson K: The presence of tumor associated macrophages in
tumor stroma as a prognostic marker for breast cancer patients. BMC
Cancer. 12:3062012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhu F, Li X, Jiang Y, Zhu H, Zhang H,
Zhang C, Zhao Y and Luo F: GdCl3 suppresses the malignant potential
of hepatocellular carcinoma by inhibiting the expression of CD206
in tumor-associated macrophages. Oncol Rep. 34:2643–2655.
2015.PubMed/NCBI
|
|
21
|
Kong LQ, Zhu XD, Xu HX, Zhang JB, Lu L,
Wang WQ, Zhang QB, Wu WZ, Wang L, Fan J, et al: The clinical
significance of the CD163+ and CD68+
macrophages in patients with hepatocellular carcinoma. PLoS One.
8:e597712013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang H, Wang X, Li X, Fan Y, Li G, Guo C,
Zhu F, Zhang L and Shi Y: CD68+HLA-DR+
M1-like macrophages promote motility of HCC cells via NF-κB/FAK
pathway. Cancer Lett. 345:91–99. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ni YH, Ding L, Huang XF, Dong YC, Hu QG
and Hou YY: Microlocalization of CD68 tumor-associated macrophages
in tumor stroma correlated with poor clinical outcomes in oral
squamous cell carcinoma patients. Tumour Biol. 36:5291–5298. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hu Y, He MY, Zhu LF, Yang CC, Zhou ML,
Wang Q, Zhang W, Zheng YY, Wang DM, Xu ZQ, et al: Tumor-associated
macrophages correlate with the clinicopathological features and
poor outcomes via inducing epithelial to mesenchymal transition in
oral squamous cell carcinoma. J Exp Clin Cancer Res. 35:122016.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cervello M, Foderàa D, Florena AM, Soresi
M, Tripodo C, DAlessandro N and Montalto G: Correlation between
expression of cyclooxygenase-2 and the presence of inflammatory
cells in human primary hepatocellular carcinoma: Possible role in
tumor promotion and angiogenesis. World J Gastroenterol.
11:4638–4643. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhu XD, Zhang JB, Zhuang PY, Zhu HG, Zhang
W, Xiong YQ, Wu WZ, Wang L, Tang ZY and Sun HC: High expression of
macrophage colony-stimulating factor in peritumoral liver tissue is
associated with poor survival after curative resection of
hepatocellular carcinoma. J Clin Oncol. 26:2707–2716. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jensen TO, Schmidt H, Møller HJ, Høyer M,
Maniecki MB, Sjoegren P, Christensen IJ and Steiniche T: Macrophage
markers in serum and tumor have prognostic impact in American Joint
Committee on Cancer stage I/II melanoma. J Clin Oncol.
27:3330–3337. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Murdoch C, Giannoudis A and Lewis CE:
Mechanisms regulating the recruitment of macrophages into hypoxic
areas of tumors and other ischemic tissues. Blood. 104:2224–2234.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhuang PY, Wang JD, Tang ZH, Zhou XP, Quan
ZW, Liu YB and Shen J: Higher proliferation of peritumoral
endothelial cells to IL-6/sIL-6R than tumoral endothelial cells in
hepatocellular carcinoma. BMC Cancer. 15:8302015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shu QH, Ge YS, Ma HX, Gao XQ, Pan JJ, Liu
D, Xu GL, Ma JL and Jia WD: Prognostic value of polarized
macrophages in patients with hepatocellular carcinoma after
curative resection. J Cell Mol Med. 20:1024–1035. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Dong P, Ma L, Liu L, Zhao G, Zhang S, Dong
L, Xue R and Chen S: CD86+/CD206+,
diametrically polarized tumor-Associated macrophages, predict
hepatocellular carcinoma patient prognosis. Int J Mol Sci.
17:3202016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li J, Zhang BZ, Qin YR, Bi J, Liu HB, Li
Y, Cai MY, Ma S, Chan KW, Xie D, et al: CD68 and interleukin 13,
prospective immune markers for esophageal squamous cell carcinoma
prognosis prediction. Oncotarget. 7:15525–15538. 2016.PubMed/NCBI
|
|
33
|
Di Caro G, Cortese N, Castino GF, Grizzi
F, Gavazzi F, Ridolfi C, Capretti G, Mineri R, Todoric J, Zerbi A,
et al: Dual prognostic significance of tumour-associated
macrophages in human pancreatic adenocarcinoma treated or untreated
with chemotherapy. Gut. 65:1710–1720. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Klein JL, Nguyen TT, Bien-Willner GA, Chen
L, Foyil KV, Bartlett NL, Duncavage EJ, Hassan A, Frater JL and
Kreisel F: CD163 immunohistochemistry is superior to CD68 in
predicting outcome in classical Hodgkin lymphoma. Am J Clin Pathol.
141:381–387. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sica A and Mantovani A: Macrophage
plasticity and polarization: In vivo veritas. J Clin Invest.
122:787–795. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Benson DD, Meng X, Fullerton DA, Moore EE,
Lee JH, Ao L, Silliman CC and Barnett CC Jr: Activation state of
stromal inflammatory cells in murine metastatic pancreatic
adenocarcinoma. Am J Physiol Regul Integr Comp Physiol.
302:R1067–R1075. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Karnevi E, Andersson R and Rosendahl AH:
Tumour-educated macrophages display a mixed polarisation and
enhance pancreatic cancer cell invasion. Immunol Cell Biol.
92:543–552. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Bernard CE, Gibbons SJ, Mann IS,
Froschauer L, Parkman HP, Harbison S, Abell TL, Snape WJ, Hasler
WL, McCallum RW, et al: Association of low numbers of
CD206-positive cells with loss of ICC in the gastric body of
patients with diabetic gastroparesis. Neurogastroenterol Motil.
26:1275–1284. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
El-Serag HB: Hepatocellular carcinoma. N
Engl J Med. 365:1118–1127. 2011. View Article : Google Scholar : PubMed/NCBI
|
